OH Pharma
MOTS-c 10 mg OH PharmaMOTS-c 10 mg OH Pharma – back of vial

Mitochondria and cellular energy · File 15

MOTS-c 10 mg

Certificate of analysis available

✓Sterility and endotoxins tested by Nelson Labs (Salt Lake City)

Purity (HPLC)99.6 %
LotGN2605
LaboratoryBTLabs
Calculate a dose →

Description

16-amino-acid peptide encoded by mitochondrial DNA, discovered in 2015.

Studied benefits

  • Improved insulin sensitivity and glucose metabolism in mice.
  • Protection against some metabolic effects of a high-fat diet.
  • Improved physical performance in several mouse models.
  • Cellular adaptation to metabolic stress.

Results reported in published research; they guarantee no effect and are not an indication for use.

🔬 What the research says
  • In mice, it improved insulin sensitivity and limited weight gain on a high-fat diet (Lee et al., 2015).
  • No published efficacy data in humans.
⚠️ Warnings and reported side effects
  • Safety profile in humans unknown.

Consult a healthcare professional before any use. If an adverse effect occurs, stop use and see a doctor.

Certificate details

Laboratory
BTLabs (West Palm Beach, FL, United States)
Report number
IF-824-QSA-TR006-BTL26632-01
Substance analyzed
Mots-C
Lot
GN2605
Analysis date
June 1, 2026
Report date
June 5, 2026
Labelled sample content
10 mg
Sample ID
005000040271675

Results

TestMethodSpecificationResult
Identity and composition (FTIR)USP <197A>Confirms the presence of the peptideConfirmedPass
Purity (HPLC)USP <621>≥ 98 %99.6 %Pass
Measured content (HPLC)USP <621>90 – 110 % de 10 mg10.3 mg (103 %)Pass
Total massUSP <41>As measured97.4 mg

According to the laboratory, this analysis covers identity, purity, content and composition. It does not cover particulates, microbial contamination or endotoxins. Sterility and endotoxins are tested separately by Nelson Labs (Salt Lake City, Utah).

How to read this certificate →

Original certificate

Certificate of analysis MOTS-c 10 mg, page 1Certificate of analysis MOTS-c 10 mg, page 2 Download the certificate (PDF)

Sources

  1. Lee et al., Cell Metabolism 2015
  2. AJMC — FDA position on peptides (August 2026)
  3. Health Canada — advisory on unauthorized injectable peptides (April 2026)

For educational purposes only. This information summarizes published studies and is neither a recommendation for use nor medical advice.

← Back to products